Midatech Pharma PLC Share Price Nasdaq
Equities
US59564R1041
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.63M 5.8M 463M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 57.92% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Stamp
CEO | Chief Executive Officer | 62 | 08/09/19 |
Dan Palmer
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 44 | 10/07/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Parker
CHM | Chairman | 65 | 19/06/22 |
Sijmen de Vries
BRD | Director/Board Member | 65 | 28/10/14 |
Stephen Stamp
CEO | Chief Executive Officer | 62 | 08/09/19 |
1st Jan change | Capi. | |
---|---|---|
-1.17% | 104B | |
+2.87% | 97.47B | |
+3.87% | 22.25B | |
-14.77% | 21.68B | |
-8.47% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |